Matthew A. Sleeman

6.7k citations
83 papers · 3.9k · 1 hit paper · h-index 34

Impact in

Papers in

    • IL-33, ST2, and ILC Pathways 13
    • Immunotherapy and Immune Responses 10
    • Immune Cell Function and Interaction 10
    • T-cell and B-cell Immunology 9
    • Asthma and respiratory diseases 15

Matthew A. Sleeman

81 papers receiving 3.8k citations

Matthew A. Sleeman's Hit Papers

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation 2019 · 348 citations
3480+2+4Years since publication100200300

Peers

Matthew A. Sleeman
Comparison fields: 5 of 113
  • Immunology and Allergy 392
  • Immunology 1.3k
  • Dermatology 318
  • Physiology 773
  • Pulmonary and Respiratory Medicine 801
Replace Shoichiro Ohta with:
Shoichiro Ohta Japan
David P. Huston United States
Kazuhiko Arima Japan
Roma Sehmi Canada
Akira Suto Japan
Marcello Bagnasco Italy
Oichi Kawanami Japan
Jochen Schmitz Germany
Mark B. Headley United States
Manel Juan Spain
Matthew A. Sleeman relative to Shoichiro Ohta Japan Shoichiro Ohta's profile →
Citations per field
00.5×1.5×2.2×
Shoichiro Ohta · 1×
Citations per year

Countries citing papers authored by Matthew A. Sleeman

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Sleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Sleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Sleeman more than expected).

Fields of papers citing papers by Matthew A. Sleeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Sleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Sleeman. The network helps show where Matthew A. Sleeman may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew A. Sleeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew A. Sleeman Line = papers co-authored together Matthew A. Sleeman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
Hit paper breakdown →
2019348
2 2010312
3 2001215
4 2014187
5 2017148
6 2001125
7 2011124
8 2017120
9 2011107
10 2017105
11 2021103
12 2019101
13 201493
14 200092
15 201990
16 200980
17 201373
18 201673
19 201971
20 201371

About Matthew A. Sleeman

Matthew A. Sleeman is a scholar working on Immunology, Physiology, Pulmonary and Respiratory Medicine, Molecular Biology and Dermatology, having authored 83 papers that have together received 3.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (15 papers), IL-33, ST2, and ILC Pathways (13 papers), Immunotherapy and Immune Responses (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Eosinophilic Esophagitis (6 papers). The work is most often cited by research in Immunology and Allergy (392 citations), Immunology (1.3k citations), Dermatology (318 citations), Physiology (773 citations) and Pulmonary and Respiratory Medicine (801 citations). Matthew A. Sleeman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Richard May, Krishnanand D. Kumble, J. Greg Murison, Deborah Clarke, Andrew Murphy, Jamie Orengo, Donna K. Finch, Lynne A. Murray, Ian K. Anderson and Christopher E. Brightling. Their work appears in journals such as Journal of Allergy and Clinical Immunology, PLoS ONE, Science Immunology, mAbs and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact